Literature DB >> 938458

Growth hormone and drug metabolism. Acute effects on microsomal mixed-function oxidase activities in rat liver.

J T Wilson, T C Spelsberg.   

Abstract

Adult male rats were subjected either to sham operation or to hypophysectomy and adrenalectomy and maintained for a total of 10 days before treatment with growth hormone. Results of the early effects of growth hormone on the activities of the mixed-function oxidases in rat liver over a 96h period after growth-hormone treatment are presented. 2. Hypophysectomy and adrenalectomy result in decreased body and liver weight and decreased drug metabolism (mixed-function oxidases). Concentrations of electron-transport-system components are also decreased. 3. In the hypophysectomized/adrenalectomized rats, growth hormone decreases the activities of the liver mixed-function oxidases and the cytochrome P-450 and cytochrome c reductases, as well as decreasing the concentration of cytochrome P-450 compared with that of control rats. Similar but less dramatic results are obtained with sham-operated rats. 4. It is concluded that whereas growth hormone enhances liver growth, including induction of many enzyme activities, it results in a decrease in mixed-function oxidase activity. Apparently, mixed-function oxidase activity decreases in liver when growth (mitogenesis) increases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938458      PMCID: PMC1172724          DOI: 10.1042/bj1540433

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  TRANSFER OF RADIOACTIVITY FROM NUCLEAR TO CYTOPLASMIC RIBONUCLEIC ACID.

Authors:  H HARRIS
Journal:  Nature       Date:  1964-04-18       Impact factor: 49.962

3.  Concentration of prolactin, growth hormone and ACTH in blood and tumor. of rats with transplantable mammotropic pituitary tumor.

Authors:  R W BATES; S MILKOVIC; M M GARRISON
Journal:  Endocrinology       Date:  1962-12       Impact factor: 4.736

4.  The enzymatic metabolism of hexobarbital (evipal).

Authors:  J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-08       Impact factor: 4.030

5.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

6.  Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies.

Authors:  A H PHILLIPS; R G LANGDON
Journal:  J Biol Chem       Date:  1962-08       Impact factor: 5.157

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Intracellular distribution of enzymes. IX. Certain purine-metabolizing enzymes.

Authors:  W C SCHNEIDER; G H HOGEBOOM
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

9.  Concomitant association between high plasma levels of growth hormone and low hepatic mixed-function oxidase activity in the young rat.

Authors:  J T Wilson; L A Frohman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

10.  The effect of a pituitary mammotropic tumor on hepatic microsomal drug metabolism in the rat.

Authors:  J T Wilson
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

View more
  4 in total

1.  Growth hormone and drug metabolism. Acute effects on nuclear ribonucleic acid polymerase activity and chromatin.

Authors:  T C Spelsberg; J T Wilson
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

2.  Attempts to phenotype human liver samples in vitro for debrisoquine 4-hydroxylase activity.

Authors:  A R Boobis; C E Hampden; S Murray; P Beaune; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

3.  Association of Vitamin D Receptor Polymorphisms With Activity of Acromegaly, Vitamin D Status and Risk of Osteoporotic Fractures in Acromegaly Patients.

Authors:  Aleksandra Jawiarczyk-Przybyłowska; Jowita Halupczok-Żyła; Katarzyna Kolačkov; Łukasz Gojny; Agnieszka Zembska; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-24       Impact factor: 5.555

4.  Role of the hypothalamo-pituitary-liver axis in sex differences in susceptibility of the liver to toxic agents.

Authors:  J A Gustafsson; P Eneroth; T Hökfelt; A Mode; G Norstedt; P Skett
Journal:  Environ Health Perspect       Date:  1981-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.